BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 15, 2001
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Pieris ProteoLab AG

Freising-Weihenstephan, Germany

Technology: Anticalin therapeutics

Disease focus: Cancer, autoimmune diseases, cardiovascular/metabolic, CNS

Read the full 55 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >